Form 4: ProAssurance Corp Merger Completes, Shares Converted to Cash

ProAssurance Corporation's merger with The Doctors Company subsidiary, Jackson Acquisition Corporation, has been finalized, converting outstanding common stock and deferred shares into cash payments.

Summary

• The filing details the completion of the merger between ProAssurance Corporation and Jackson Acquisition Corporation, a subsidiary of The Doctors Company, effective June 26, 2026.
• As a result of the merger, all outstanding shares of ProAssurance Corporation's common stock were converted into the right to receive $25.00 in cash per share.
• Deferred shares awarded under the ProAssurance Corporation Director Deferred Stock Compensation Plan were also converted into a cash payment based on the merger consideration.
• The reporting person, Staci Pierce, a Director, had 10,621 shares of common stock beneficially owned, which were subject to these conversion terms.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it primarily reports on the completion of a merger and the conversion of securities into cash, rather than new operational or financial performance data.

Positives

• The merger has been successfully completed, indicating a resolution for ProAssurance Corporation's shareholders.
• Shareholders are receiving a cash payout of $25.00 per share, providing immediate liquidity.

Negatives

• Common stock and deferred shares are no longer outstanding, meaning shareholders will not participate in any future upside of ProAssurance Corporation as an independent entity.
• The conversion to cash implies the delisting of ProAssurance Corporation from public trading.

Risks

• The filing does not explicitly mention any risks associated with the merger completion itself, but the conversion to cash means shareholders forgo potential future growth.
• The merger agreement was dated March 19, 2025, and the transaction closed on June 26, 2026, indicating a significant period between agreement and completion, which could have introduced unforeseen risks during that time.

Future Outlook

The filing primarily reports on a completed transaction. There are no explicit forward-looking statements or guidance provided regarding the future operations of the merged entity or the reporting person's future transactions.

Management Comments

• The filing indicates that the merger was executed pursuant to a specific Agreement and Plan of Merger.
• Deferred shares and accrued dividend equivalents were converted into the right to receive cash based on the merger consideration.

Industry Context

StockSavvy.ai notes that this Form 4 filing signifies the completion of a significant M&A event in the insurance sector, specifically involving a merger between ProAssurance Corporation and The Doctors Company. Such transactions are often driven by market consolidation, strategic alignment, or the pursuit of enhanced scale and efficiency within the healthcare liability insurance market.

Stakeholder Impact

• Shareholders: Will receive $25.00 per share in cash, realizing their investment in ProAssurance Corporation.
• Employees: The filing does not detail the impact on employees, but mergers often involve integration and potential restructuring.
• Creditors: The merger terms and continued operation under The Doctors Company would dictate the impact on creditors.

Next Steps

• Shareholders will receive the cash consideration for their shares.
• ProAssurance Corporation will operate as a wholly owned subsidiary of The Doctors Company.

Key Dates

Keywords

ProAssurance Corp, Merger, The Doctors Company, Jackson Acquisition Corporation, Form 4, SEC Filing, Director, Common Stock, Deferred Shares, Cash Consideration